Want to see HK:6929 full AI Analyst Report?
OrbusNeich Medical Group Holdings Limited (6929) Ratios
OrbusNeich Medical Group Holdings Limited Ratios
HK:6929's free cash flow for Q2 2026 was $12.75M. For the 2026 fiscal year, HK:6929's free cash flow was decreased by $-13.70M and operating cash flow was $26.45M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.54 | 11.77 | 9.77 | 13.20 | 14.31 |
| Quick Ratio | 8.51 | 9.93 | 8.60 | 11.96 | 12.51 |
| Cash Ratio | 6.57 | 8.09 | 7.18 | 9.62 | 10.69 |
| Solvency Ratio | 1.24 | 1.14 | 1.21 | 0.79 | -0.00 |
| Operating Cash Flow Ratio | 0.59 | 0.43 | 0.65 | 0.98 | 1.25 |
| Short-Term Operating Cash Flow Coverage | 8.73 | 0.00 | 5.44 | 0.00 | 0.00 |
| Net Current Asset Value | $ 311.91M | $ 324.82M | $ 307.24M | $ 285.78M | $ 149.94M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.25 |
| Debt-to-Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.37 |
| Debt-to-Capital Ratio | 0.01 | 0.01 | 0.02 | 0.01 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.26 |
| Financial Leverage Ratio | 1.10 | 1.10 | 1.11 | 1.09 | 1.47 |
| Debt Service Coverage Ratio | 16.84 | 156.16 | 11.29 | 16.29 | 0.92 |
| Interest Coverage Ratio | 236.54 | 147.09 | 281.26 | 14.40 | 3.47 |
| Debt to Market Cap | 0.01 | 0.00 | 0.01 | 0.00 | 0.09 |
| Interest Debt Per Share | 0.00 | 0.01 | 0.01 | 0.01 | 0.13 |
| Net Debt to EBITDA | -4.71 | -6.65 | -4.60 | -8.30 | -13.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.85% | 69.76% | 69.22% | 67.57% | 69.70% |
| EBIT Margin | 21.80% | 21.22% | 32.34% | 17.00% | 3.68% |
| EBITDA Margin | 25.25% | 22.40% | 35.07% | 19.83% | 7.13% |
| Operating Profit Margin | 22.02% | 19.63% | 25.96% | 15.40% | 16.69% |
| Pretax Profit Margin | 26.09% | 25.84% | 32.25% | 15.93% | -1.13% |
| Net Profit Margin | 23.22% | 24.20% | 29.29% | 13.51% | -3.82% |
| Continuous Operations Profit Margin | 23.29% | 24.28% | 29.29% | 13.51% | -3.82% |
| Net Income Per EBT | 88.98% | 93.66% | 90.82% | 84.86% | 337.18% |
| EBT Per EBIT | 118.49% | 131.65% | 124.26% | 103.41% | -6.78% |
| Return on Assets (ROA) | 9.25% | 9.21% | 10.99% | 5.27% | -1.65% |
| Return on Equity (ROE) | 10.15% | 10.10% | 12.23% | 5.73% | -2.43% |
| Return on Capital Employed (ROCE) | 9.47% | 8.05% | 10.66% | 6.44% | 7.71% |
| Return on Invested Capital (ROIC) | 8.37% | 7.53% | 9.53% | 5.44% | 7.67% |
| Return on Tangible Assets | 9.74% | 9.66% | 11.54% | 5.37% | -1.70% |
| Earnings Yield | 10.92% | 10.05% | 6.00% | 2.27% | -0.66% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.43 | 3.17 | 4.05 | 4.23 | 4.34 |
| Payables Turnover | 12.35 | 7.26 | 9.84 | 10.91 | 16.23 |
| Inventory Turnover | 0.86 | 0.88 | 1.14 | 1.51 | 1.19 |
| Fixed Asset Turnover | 3.98 | 5.95 | 8.33 | 10.29 | 9.02 |
| Asset Turnover | 0.40 | 0.38 | 0.38 | 0.39 | 0.43 |
| Working Capital Turnover Ratio | 0.56 | 0.51 | 0.51 | 0.54 | 0.98 |
| Cash Conversion Cycle | 501.13 | 479.22 | 372.18 | 294.66 | 367.39 |
| Days of Sales Outstanding | 106.47 | 115.26 | 90.06 | 86.23 | 84.04 |
| Days of Inventory Outstanding | 424.21 | 414.27 | 319.22 | 241.87 | 305.84 |
| Days of Payables Outstanding | 29.55 | 50.30 | 37.10 | 33.44 | 22.49 |
| Operating Cycle | 530.68 | 529.52 | 409.28 | 328.10 | 389.88 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.02 | 0.03 | 0.03 | 0.04 |
| Free Cash Flow Per Share | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 |
| Dividend Paid and CapEx Coverage Ratio | 0.43 | 0.60 | 3.08 | 7.03 | 9.57 |
| Capital Expenditure Coverage Ratio | 1.06 | 1.16 | 3.08 | 7.03 | 9.57 |
| Operating Cash Flow Coverage Ratio | 4.99 | 3.12 | 3.09 | 5.82 | 0.30 |
| Operating Cash Flow to Sales Ratio | 0.11 | 0.08 | 0.15 | 0.17 | 0.18 |
| Free Cash Flow Yield | 0.30% | 0.47% | 2.07% | 2.46% | 2.71% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 9.14 | 9.95 | 16.68 | 44.11 | -152.32 |
| Price-to-Sales (P/S) Ratio | 2.13 | 2.41 | 4.89 | 5.96 | 5.81 |
| Price-to-Book (P/B) Ratio | 0.93 | 1.00 | 2.04 | 2.53 | 3.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 333.81 | 214.47 | 48.34 | 40.59 | 36.87 |
| Price-to-Operating Cash Flow Ratio | 19.64 | 30.14 | 32.64 | 34.81 | 33.02 |
| Price-to-Earnings Growth (PEG) Ratio | 1.57 | -0.90 | 0.24 | -0.09 | 0.94 |
| Enterprise Value Multiple | 3.70 | 4.10 | 9.33 | 21.76 | 68.47 |
| Enterprise Value | 168.78M | 150.88M | 503.52M | 590.56M | 568.71M |
| EV to EBITDA | 3.70 | 4.10 | 9.33 | 21.76 | 68.47 |
| EV to Sales | 0.94 | 0.92 | 3.27 | 4.32 | 4.88 |
| EV to Free Cash Flow | 146.90 | 81.87 | 32.37 | 29.39 | 30.98 |
| EV to Operating Cash Flow | 8.64 | 11.51 | 21.86 | 25.20 | 27.74 |
| Tangible Book Value Per Share | 0.47 | 0.45 | 0.42 | 0.44 | 0.31 |
| Shareholders’ Equity Per Share | 0.50 | 0.48 | 0.44 | 0.45 | 0.32 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.11 | 0.06 | 0.09 | 0.15 | -2.37 |
| Revenue Per Share | 0.22 | 0.20 | 0.18 | 0.19 | 0.20 |
| Net Income Per Share | 0.05 | 0.05 | 0.05 | 0.03 | -0.01 |
| Tax Burden | 0.89 | 0.94 | 0.91 | 0.85 | 3.37 |
| Interest Burden | 1.20 | 1.22 | 1.00 | 0.94 | -0.31 |
| Research & Development to Revenue | 0.09 | 0.10 | 0.10 | 0.11 | 0.10 |
| SG&A to Revenue | 0.37 | 0.38 | 0.12 | 0.16 | 0.17 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 0.41 | 0.31 | 0.51 | 1.08 | -15.55 |
Currency in USD
